Home > Actueel > Publicaties

PUBLICATIES

Hieronder staat een reeks publicaties van Wemos door de jaren heen. Meer recente publicaties op het gebied van onze programma’s zorgpersoneel, financiering voor gezondheid en medicijnen zijn te vinden op ons kennisplatform (wemosresources.org).

Strategie 2019-2023, jaarrekening en -overzicht 2018

Year Overview 2018

Jaarrekening 2018

Strategy 2019-2023

Strategy 2019-2023 (extended version)

Voorgaande jaarrapporten en beleidsplannen

Strategisch beleidsplan 2016-2020

Korte publieksversie Strategisch beleidsplan 2016-2020

Strategisch beleidsplan 2013-2015

Infographics

2019 The System of Medicine Development (and what the EU and the Netherlands can do about it)

2018 Financing for Health (SDG3): Shared global responsibility – an analysis of five African countries

2017 Universal Health Coverage: a pool for a plan for UHC

Zorgpersoneel

2018 Remco van de Pas, Linda Mans, Mariëlle Bemelmans, Anja Krumeich: Framing the Health Workforce Agenda Beyond Economic Growth

2018 Factsheet ‘Introduction to Health Labour Market Analysis’

2018 Factsheet ‘Human Resources for Health: The WHO Code of Practice on the International Recruitment of Health Personnel’

2018 Factsheet ‘Human Resources for Health: Global Agreements’

2018 World Health Organization: current issues and advocacy opportunities for civil society organizations

2017 Linda Mans, Remco van de Pas, Sascha Marschang: Civil society contributions to a sustainable health workforce in the European Union (in: Public Health Panorama 2017; 3(3):357-536)

2016 Remco van de Pas, Linda Mans, e.a.: The Code of Practice and its enduring relevance in Europe and Eastern and Southern Africa

2016 Health Workers for All and All for Health Workers. Country and joint activities and project results. European project 2013-2015

2015 Amy Davies en Linda Mans: Thuisbezorgd – inwonende buitenlandse zorgverleners als oplossing?

2014 Health workforce shortages and international mobility in the EU

2013 Zorgen voor zorgende handen – ver van ons bed?

Goed bestuur & Financiering van gezondheid

2019 The Global Financing Facility in Malawi

2019 The Global Financing Facility in Uganda

2019 The Global Financing Facility in Kenya

2019 Factsheet: ‘Fiscal space for health and four ways to increase it’

2019 Factsheet: ‘The Global Financing Facility’

2018 Factsheet: ‘Public Finance Targets for Universal Health Coverage (UHC)’

2017 Factsheet: ‘Global Health Strategy in theorie en praktijk’

2005 Risky remedies for the health of the poor. Global public-private initiatives in health. Report on the implementation of four GPPIs in five African countries and three Indian States

2005 Risky remedies for the health of the poor. Global public-private initiatives in health. Summary and recommendations. Report on the implementation of four GPPIs in five African countries and three Indian States

Medicijnen

2019 SOMO & Wemos: ‘Overpriced – Drugs developed with Dutch public funding’ en Samenvatting van ‘Overpriced’

2017 Ella Weggen en Corinne Hinlopen: ‘Independent clinical research: a road towards affordable & valuable medicines’

2017 Clinical trials in Africa: the cases of Egypt, Kenya, Zimbabwe and South Africa

2017 Pearl Heinemans, Irene Schipper, Patrick Durisch: ‘Transnational pharmaceutical companies’ clinical drug trials in Egypt: ethical questions in a challenging context’ in: Dirty Profits 5.

2016 ‘Industry-sponsored clinical drug trials in Egypt: ethical questions in a challenging context’

2016 Annelies den Boer en Amy Davies: ‘Clinical trials in Africa: an exploitative relationship’ in: Dirty Profits 4.

2015 Clinical Trials Realities in Zimbabwe: Dealing with Possible Unethical Research

2015 Joint briefing paper: ”Adaptive licensing’ or ‘adaptive pathways’: deregulation under the guise of earlier access’

2014 Position paper: ‘Added Therapeutic Value: European citizens should get their money’s worth’

2014 The Clinical Trials Industry in Kenya: Realities, Risks and Challenges

2013 The Clinical Trials Industry in South Africa: Ethics, Rules and Realities

2013 Pecha Kucha: Anke Tijtsma over eerlijke medicijnen

2011 Briefing paper: Protection of Clinical Trial Participants in Countries Outside the EU

2010 The Globalization of Clinical Trials: Testimonies from Human Subjects

2008 Een bittere pil: de risico’s van klinisch geneesmiddelenonderzoek in ontwikkelingslanden

2008 SOMO Briefing paper on ethics in clinical trials: Examples of unethical trials

2007 Controleren Europese registratieautoriteiten of geneesmiddelenonderzoek in ontwikkelingslanden op ethische wijze wordt uitgevoerd?

Schadelijke stoffen

2018 Nationaal plan: hormoonverstorende stoffen in een circulaire economie

2016 Wemos: Factsheet ‘Dit moet je weten over hormoonverstorende stoffen’

2016 Wemos en WECF: ‘Maatregelen tegen hormoonverstorende stoffen: het voorbeeld van Denemarken, Zweden en Frankrijk’

2016 Annelies den Boer, Marjorie van Duursen e.a.: ‘Help hormoonverstorende stoffen de wereld uit’ in: Medisch Contact 20/2016

Monitor Internationale Gezondheidsuitdagingen

Wemos publiceert een monitor over de onderwerpen die besproken worden tijdens de belangrijkste jaarlijkse vergaderingen van de Wereldgezondheidsorganisatie: Executive Board (januari), World Health Assembly (mei) en WHO Euro (september).

2016 Juni: Monitor 69e World Health Assembly

2016 Februari: Monitor 138e vergadering Executive Board WHO